92 results
Page 5 of 5
6-K
EX-99.1
5xjac
5 Jun 19
GENFIT Launches a Phase 2 Trial Evaluating Elafibranor on Hepatic Lipid Composition for NAFL
7:40am
6-K
EX-99.1
0watxhj
23 May 19
GENFIT Launches a Combination Therapy Clinical Program in NASH
5:13pm
6-K
EX-99.3
el7e83croejzzowl
14 May 19
Shareholders' and Unitholders' Meetings
9:29am
6-K
EX-99.1
vmw37cruq9rqbyj t6qa
30 Apr 19
Current report (foreign)
8:01am
6-K
EX-99.1
7c2pyx8
18 Apr 19
GENFIT Announces FDA Grant of Breakthrough Therapy Designation to Elafibranor for the Treatment of PBC
6:04am
6-K
EX-99.1
6awvoc2ft06t7 az8434
15 Apr 19
GENFIT to Present Additional Data from the Positive Phase 2
8:01am
424B4
5a0cx2iv1wyh xj9tzw
27 Mar 19
Prospectus supplement with pricing info
4:12pm
F-1/A
zp4wfuc3pcx
14 Mar 19
Registration statement (foreign) (amended)
12:54pm
F-1
d17uboww 49
27 Feb 19
Registration statement (foreign)
2:11pm
DRS/A
jwavpuo
15 Feb 19
Draft registration statement (amended)
12:00am
DRS/A
xq3yj45z71gc
21 Dec 18
Draft registration statement (amended)
12:00am
DRS
f18wsr03np5fud6u
16 Nov 18
Draft registration statement
12:00am